McDonald's Corp (MCD) Falls 4.54% for February 05

Equities Staff |

One of the S&P 500’s big losers for Friday February 05 was McDonald's Corp (MCD). The company’s stock fell 4.54% to $115.19 on volume of 9.96 million shares.

The stock opened the day at 120.65 and traded between a low of $115.07 and a high of $120.65. The stock finished the day down $5.475 per share. McDonald's Corp has an average daily volume of 6.99 million and a total float of 918.23 million shares. The 50-day SMA for McDonald's Corp is $117.56 and its 200-day SMA is $103.27. The high for the stock over the last 52 weeks is $124.83 and the low is $87.50.

McDonald's Corp franchises and operates McDonald's restaurants in the food service industry. Its geographic segments include the United States, Europe, and Asia-Pacific, Middle East and Africa.

McDonald's Corp is centered in Oak Brook, IL, and has 420,000 employees. Today’s trading day leaves the company with a market cap of $105.77 billion. The company has a P/S ratio of n/a, P/B ratio of 12.73, and a 66.6.

For a complete fundamental analysis analysis of McDonald's Corp, check out’s Stock Valuation Analysis report for MCD. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.